Independent pharmacies increasingly sell high‑margin CBD oils while major chains hold back
Independent pharmacies increasingly sell high‑margin CBD oils while major chains hold back The passage is a routine market analysis of CBD product adoption in pharmacies. It mentions no specific high‑profile individuals, government actions, or illicit financial flows. The only potentially actionable detail is the observation that large chains like CVS, Walgreens, and WBA are monitoring but not yet selling CBD, which offers minimal investigative value. Key insights: Independent pharmacies are expanding CBD oil sales, citing high margins and patient demand.; National Community Pharmacists Association held an educational panel on CBD legality and use in Oct 2018.; Large U.S. chains (CVS, Walgreens) have not yet entered the CBD market, though WBA monitors it.
Summary
Independent pharmacies increasingly sell high‑margin CBD oils while major chains hold back The passage is a routine market analysis of CBD product adoption in pharmacies. It mentions no specific high‑profile individuals, government actions, or illicit financial flows. The only potentially actionable detail is the observation that large chains like CVS, Walgreens, and WBA are monitoring but not yet selling CBD, which offers minimal investigative value. Key insights: Independent pharmacies are expanding CBD oil sales, citing high margins and patient demand.; National Community Pharmacists Association held an educational panel on CBD legality and use in Oct 2018.; Large U.S. chains (CVS, Walgreens) have not yet entered the CBD market, though WBA monitors it.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.